Seema Gorla

3PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 05, 2026
Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9.

|Oct 31, 2024
Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer.

Paul L Swiecicki, Emrullah Yilmaz, Ari Joseph Rosenberg

Pageof 1

Frequent Collaborators

3 joint publications

Paul L Swiecicki

3 joint publications

Ari Joseph Rosenberg

3 joint publications

Takao Fujisawa

3 joint publications

Justine Yang Bruce